WASHINGTON (dpa-AFX) - Wednesday, AbbVie Inc. (ABBV) announced the
appointment of Roopal Thakkar as the executive vice president of research and
development and chief scientific officer. This comes as Thomas Hudson, the
current senior vice president and chief scientific officer of global research at
AbbVie, is set to retire.

In his new position, Thakkar will oversee AbbVie's global R&D organization,
which comprises of over 14,000 team members.
He will lead the company's six major R&D centers of excellence situated in the
United States, Germany, and Japan.

Thakkar, who currently serves as the senior vice president and chief medical
officer of global therapeutics, first joined the company in 2003 through the
Physician Development Program.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX